申请人:Mazik Monika
公开号:US20100113505A1
公开(公告)日:2010-05-06
The present invention relates to new compounds having an amino-naphthyridine group. In particular, the present invention relates to new compounds, its stereoisomers and pharmaceutically acceptable salts or solvates thereof having a first unit (moiety) selected from the group of a phenyl derivative, a biphenyl derivative or a diphenyl alkane derivative and at least one amino-naphthyridine group linked with the first unit via a linking group. In specific embodiments, the present invention relates to compounds having a phenyl derivative unit and three amino-naphthyridine groups bound to the phenyl derivative unit via a linking group as well as salts or solvates thereof, in particular, pharmaceutically acceptable salts or solvates thereof. Further, the present invention relates to pharmaceutical compositions comprising said compounds. The compounds are particularly useful for treating or preventing infections, like viral infections.
本发明涉及具有氨基萘啉基团的新化合物。具体而言,本发明涉及新化合物、其立体异构体以及药学上可接受的盐或溶剂化物,其具有从苯基衍生物、联苯基衍生物或二苯基烷基衍生物组成的第一单元(基团),并且至少有一个氨基萘啉基团通过连接基团与第一单元相连。在具体实施例中,本发明涉及具有苯基衍生物单元和三个氨基萘啉基团通过连接基团与苯基衍生物单元相连的化合物,以及其盐或溶剂化物,特别是药学上可接受的盐或溶剂化物。此外,本发明涉及包含所述化合物的药物组合物。这些化合物特别适用于治疗或预防感染,如病毒感染。